Pre-vascular microtissues delivered in a microhydrogel injection are better able to lay the groundwork necessary for blood vessels to grow. Cell-based strategies are seen as true game changers in the context of ischemic vascular diseases because they aim to cure and not simply to ameliorate these diseases.